FASN and colorectal carcinoma: In addition, consistent with our results, the expression of FASN has been reported to be significantly increased in CRC tissues and to be associated with the development of CRC and liver metastasis.[78] In addition, inhibition of de novo lipogenesis has been recognized as a promising therapeutic target in CRC treatment.[79] In our study, the increased acetyl‐CoA levels induced by the EBV‐miR‐BART18‐3p axis enhanced the acetylation levels of histones H3K9, H3K14, and H3K27, which upregulated FASN expression and increased de novo lipogenesis.